Effect of Sildenafil for the Treatment of Sustained Pulmonary Artery Hypertension After Corrected Mitral Valve Disease
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms SUPERIOR
- 09 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 09 Jan 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 11 Jul 2016 Status changed from not yet recruiting to active, no longer recruiting.